ZAMPIERI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.258
NA - Nord America 2.118
EU - Europa 1.958
SA - Sud America 250
OC - Oceania 35
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.650
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.074
RU - Federazione Russa 1.040
CN - Cina 721
SG - Singapore 715
IT - Italia 303
HK - Hong Kong 289
KR - Corea 258
BR - Brasile 191
IE - Irlanda 129
DE - Germania 101
VN - Vietnam 96
SE - Svezia 82
GB - Regno Unito 73
FI - Finlandia 67
IN - India 64
FR - Francia 36
AU - Australia 35
AR - Argentina 32
ID - Indonesia 32
JO - Giordania 31
CH - Svizzera 21
MX - Messico 20
NL - Olanda 19
DK - Danimarca 18
CA - Canada 15
ES - Italia 15
EC - Ecuador 11
JP - Giappone 11
PL - Polonia 11
UA - Ucraina 9
BD - Bangladesh 7
ZA - Sudafrica 7
BE - Belgio 6
AE - Emirati Arabi Uniti 5
BJ - Benin 5
IQ - Iraq 5
MA - Marocco 5
PY - Paraguay 5
RS - Serbia 5
TR - Turchia 5
AT - Austria 4
CL - Cile 4
CZ - Repubblica Ceca 4
EG - Egitto 4
VE - Venezuela 4
AL - Albania 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
PA - Panama 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
ZM - Zambia 1
Totale 6.650
Salva come PNG Salva come JPEG
Città #
Santa Clara 856
Singapore 521
Hefei 317
Hong Kong 259
Seoul 258
Ashburn 252
Dublin 127
Beijing 75
Los Angeles 61
Munich 58
Chandler 56
Florence 54
Moscow 50
Kent 42
Fairfield 37
New York 35
Ho Chi Minh City 34
Melbourne 34
Buffalo 33
Shanghai 30
Dallas 29
Jakarta 28
Helsinki 27
Seattle 26
Altamura 23
Lawrence 23
Mumbai 21
Turku 21
Houston 20
Bengaluru 19
Hanoi 19
Copenhagen 18
Lappeenranta 18
Ann Arbor 17
Frankfurt am Main 17
London 17
Woodbridge 17
Bern 16
Milan 16
Rome 16
Boston 15
Cambridge 15
Naples 15
Princeton 14
West Jordan 14
São Paulo 13
Düsseldorf 11
Prato 11
Chennai 10
Yubileyny 10
Chicago 9
Tokyo 9
Paris 8
Phoenix 8
Pune 8
The Dalles 8
Medford 7
Orem 7
Poplar 7
Rio de Janeiro 7
San Diego 7
Wilmington 7
Hillsboro 6
San Francisco 6
Stockholm 6
Toronto 6
Warsaw 6
Atlanta 5
Belgrade 5
Biên Hòa 5
Brussels 5
Buenos Aires 5
Changsha 5
Cotonou 5
Da Nang 5
Guayaquil 5
Inverurie 5
Johannesburg 5
Lecce 5
Manaus 5
Manchester 5
Mexico City 5
Bologna 4
Lodi 4
Montreal 4
Pisa 4
Porto Alegre 4
Wroclaw 4
Zurich 4
Abidjan 3
Ankara 3
Baghdad 3
Belo Horizonte 3
Boardman 3
Brasília 3
Brooklyn 3
Bắc Giang 3
Cairo 3
Canoas 3
City of London 3
Totale 3.983
Salva come PNG Salva come JPEG
Nome #
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 231
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 189
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 174
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 164
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 162
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 160
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis 153
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 152
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 150
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 146
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 145
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 144
Standard Therapy in Cardiac Amyloidosis 144
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 142
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 139
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 138
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 137
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 136
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 135
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 133
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 133
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 130
Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis 130
Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgery 129
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 129
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 128
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 128
Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? 127
Diagnostic Pathways to Wild-Type Transthyretin Amyloid Cardiomyopathy: a Multicenter Network Study 126
SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series 126
Prevalence of carpal tunnel syndrome in patients with transthyretin cardiac amyloidosis 125
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 125
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 124
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 122
Stage-specific therapy for hypertrophic cardiomyopathy 122
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 121
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease 121
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 121
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 118
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 116
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 114
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 113
Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis 111
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 110
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 109
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 109
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis 107
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 102
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 100
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 91
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 86
Totale 6.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 5 3 4 12 3 15 3
2021/2022130 8 4 5 9 4 10 6 6 16 12 19 31
2022/2023543 22 75 15 16 55 81 102 34 58 18 28 39
2023/2024548 30 39 46 30 36 68 33 132 12 54 32 36
2024/20253.015 86 282 161 485 759 378 87 151 148 74 169 235
2025/20262.358 400 551 573 388 405 41 0 0 0 0 0 0
Totale 6.727